ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Value Contribution of Etranacogene Dezaparvovec for the Treatment of Severe and Moderately Severe Haemophilia B in Spain Through Multicriteria Decision Analysis (MCDA)
Nov 19, 2024, 16:00 PM
«
901
902
903
904
(current)
905
906
907
908
909
910
»